These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6200312

  • 1. [Serotoninergic depression--hypothesis or reality?].
    Leboyer M, Plaisant O.
    Encephale; 1983; 9(4):317-30. PubMed ID: 6200312
    [Abstract] [Full Text] [Related]

  • 2. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF, Risch SC.
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [Abstract] [Full Text] [Related]

  • 3. [Reduced serotonin levels are predisposing to violence. A simple blood test predicts dangerous character].
    Lidberg L, Dåderman A.
    Lakartidningen; 1997 Sep 24; 94(39):3385-8. PubMed ID: 9379806
    [Abstract] [Full Text] [Related]

  • 4. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments.
    Møller SE.
    Acta Psychiatr Scand Suppl; 1985 Sep 24; 325():3-31. PubMed ID: 2418637
    [Abstract] [Full Text] [Related]

  • 5. HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: a methodological study with clinical applications.
    Larsson M, Forsman A, Hallgren J.
    Methods Find Exp Clin Pharmacol; 1988 Jul 24; 10(7):453-60. PubMed ID: 2458513
    [Abstract] [Full Text] [Related]

  • 6. [The concept of serotonergic depression].
    Plaisant O, Leboyer M, Debray Q, Pelicier Y.
    Ann Med Interne (Paris); 1983 Jul 24; 134(8):691-4. PubMed ID: 6198949
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic implications of the biochemical features about depressive illness (author's transl)].
    Lôo H.
    Encephale; 1981 Jul 24; 7(4 Suppl):429-40. PubMed ID: 6172268
    [Abstract] [Full Text] [Related]

  • 8. [Serotoninergic and catecholaminergic indices in patients with neurotic and depressive disorders and changes in them as a result of reflexotherapy].
    Markelova VF, Belitskaia RA, Mikhaĭlova AA, Shumova OV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Jul 24; 86(11):1708-12. PubMed ID: 2433857
    [Abstract] [Full Text] [Related]

  • 9. Serotonergic dysfunction in depression.
    Meltzer H.
    Br J Psychiatry Suppl; 1989 Dec 24; (8):25-31. PubMed ID: 2692637
    [Abstract] [Full Text] [Related]

  • 10. [Suicide and biology].
    Boyer P.
    Ann Med Psychol (Paris); 1985 Dec 24; 143(8):782-7. PubMed ID: 2421626
    [No Abstract] [Full Text] [Related]

  • 11. Management of depression with serotonin precursors.
    van Praag HM.
    Biol Psychiatry; 1981 Mar 24; 16(3):291-310. PubMed ID: 6164407
    [Abstract] [Full Text] [Related]

  • 12. [The platelet model applied to the study of depressive illness (author's transl)].
    Dreux C, Launay JM, Giret M.
    Ann Biol Clin (Paris); 1979 Mar 24; 37(1):41-7. PubMed ID: 443612
    [Abstract] [Full Text] [Related]

  • 13. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
    Geracioti TD, Loosen PT, Ekhator NN, Schmidt D, Chambliss B, Baker DG, Kasckow JW, Richtand NM, Keck PE, Ebert MH.
    Depress Anxiety; 1997 Mar 24; 6(3):89-94. PubMed ID: 9442982
    [Abstract] [Full Text] [Related]

  • 14. [Development of biological psychiatric depression research (author's transl)].
    Matussek N.
    MMW Munch Med Wochenschr; 1981 May 08; 123(19):793-4. PubMed ID: 6262640
    [Abstract] [Full Text] [Related]

  • 15. [Biochemical aspects of depression (author's transl)].
    Duchemin AM.
    Sem Hop; 1981 May 08; 57(15-16):745-50. PubMed ID: 6269184
    [Abstract] [Full Text] [Related]

  • 16. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.
    Goodwin FK, Post RM.
    Br J Clin Pharmacol; 1983 May 08; 15 Suppl 3(Suppl 3):393S-405S. PubMed ID: 6190490
    [Abstract] [Full Text] [Related]

  • 17. [Urinary excretion of 5-hydroxyindoleacetic acid and serum tryptophan and serotonin levels in patients with depression].
    Pietruszewska I, Jasińska M, Lewicka-Wysocka H, Marcjan K, Stencka K.
    Psychiatr Pol; 1984 May 08; 18(1):9-16. PubMed ID: 6204348
    [No Abstract] [Full Text] [Related]

  • 18. Serotonin precursors in the treatment of depression.
    van Praag HM.
    Adv Biochem Psychopharmacol; 1982 May 08; 34():259-86. PubMed ID: 6753514
    [Abstract] [Full Text] [Related]

  • 19. Serotonin and its place in the pathogenesis of depression.
    Coppen AJ, Doogan DP.
    J Clin Psychiatry; 1988 Aug 08; 49 Suppl():4-11. PubMed ID: 3045111
    [Abstract] [Full Text] [Related]

  • 20. [Proserotoninergic agents and depression (author's transl)].
    Uzan A.
    Encephale; 1982 Aug 08; 8(2):273-89. PubMed ID: 6286277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.